Luminous blue variables are antisocial: their isolation implies that they are kicked mass gainers in binary evolution by Smith, Nathan, Tombleson, Ryan

Request full text

Ground-based near-UV observations of 15 transiting exoplanets: constraints on their atmospheres and no evidence for asymmetrical transits by Turner, Jake D., Pearson, Kyle A., Biddle, Lauren I., Smart, Brianna M., Zellem, Robert T., Teske, Johanna K., Hardegree-Ullman, Kevin K., Griffith, Caitlin C., Leiter, Robin M., Cates, Ian T., Nieberding, Megan N., Smith, Carter-Thaxton W., Thompson, Robert M., Hofmann, Ryan, Berube, Michael P., Nguyen, Chi H., Small, Lindsay C., Guvenen, Blythe C., Richardson, Logan, McGraw, Allison, Raphael, Brandon, Crawford, Benjamin E., Robertson, Amy N., Tombleson, Ryan, Carleton, Timothy M., Towner, Allison P.M., Walker-LaFollette, Amanda M., Hume, Jeffrey R., Watson, Zachary T., Jones, Christen K., Lichtenberger, Matthew J., Hoglund, Shelby R., Cook, Kendall L., Crossen, Cory A., Jorgensen, Curtis R., Romine, James M., Thompson, Alejandro R., Villegas, Christian F., Wilson, Ashley A., Sanford, Brent, Taylor, Joanna M., Henz, Triana N.

Request full text

Luminous Blue Variables are Antisocial: Their Isolation Implies that they are Kicked Mass Gainers in Binary Evolution by Smith, Nathan, Ryan Tombleson

Get full text

Ground-based near-UV observations of 15 transiting exoplanets: Constraints on their atmospheres and no evidence for asymmetrical transits by Turner, Jake D, Pearson, Kyle A, Biddle, Lauren I, Smart, Brianna M, Zellem, Robert T, Teske, Johanna K, Hardegree-Ullman, Kevin K, Griffith, Caitlin C, Leiter, Robin M, Cates, Ian T, Nieberding, Megan N, Smith, Carter-Thaxton W, Thompson, Robert M, Hofmann, Ryan, Berube, Michael P, Nguyen, Chi H, Small, Lindsay C, Guvenen, Blythe C, Richardson, Logan, McGraw, Allison, Brandon, Raphael, Crawford, Benjamin E, Robertson, Amy N, Ryan Tombleson, Carleton, Timothy M, Towner, Allison P M, Walker-LaFollette, Amanda M, Hume, Jeffrey R, Watson, Zachary T, Jones, Christen K, Lichtenberger, Matthew J, Hoglund, Shelby R, Cook, Kendall L, Crossen, Cory A, Jorgensen, Curtis R, James M Romine Alejandro R Thompson, Villegas, Christian F, Wilson, Ashley A, Sanford, Brent, Taylor, Joanna M

Get full text

Characterization of collaborative practice agreements held by hematopoietic stem cell transplant pharmacists by Bryk, Amy, Koontz, Susannah, Mayor, JoAl, Betcher, Jeffrey, Tombleson, Rebecca, Bookout, Ryan, Saunders, Ila M

Get full text

Reduced-intensity fludarabine/melphalan confers similar survival to busulfan/fludarabine myeloablative regimens for patients with acute myeloid leukemia and myelodysplasia by DiMaggio, Elizabeth, Zhou, Jun-Min, Caddell, Ryan, Tombleson, Rebecca, Perkins, Janelle, Anasetti, Claudio, Khimani, Farhad, Pidala, Joseph, Nishihori, Taiga, Perez, Lia, Betts, Brian, Fernandez, Hugo F., Mishra, Asmita

Get full text

Fludarabine and Melphalan Results in Fewer Relapses Compared to Fludarabine and Targeted Busulfan in Patients Receiving Reduced Intensity Conditioning for AML and MDS by Caddell, Ryan James, Schaible, Braydon, Ma, Zhenjun, Dimaggio, Elizabeth, Tombleson, Rebecca, Anasetti, Claudio, Ayala, Ernesto, Betts, Brian C., Kharfan-Dabaja, Mohamed A., Locke, Frederick L., Nishihori, Taiga, Pidala, Joseph A., Fernandez, Hugo F., Mishra, Asmita

Get full text

Evaluation of a Risk-Based Algorithm for the Utilization of Plerixafor As Primary Mobilization of CD34+ Cells in Autologous Hematopoietic Cell Transplant Candidates by Shapiro, Jamie, Perkins, Janelle, Bookout, Ryan, Tombleson, Rebecca, Ayala, Ernesto, Janssen, William E., Anasetti, Claudio, Fernandez, Hugo F.

Get full text

Characterization of Collaborative Practice Agreements (CPA) Held By Hematopoietic Cell Transplant (HCT) Pharmacists by Bryk, Amy Wiglesworth, PharmD, Koontz, Susannah, PharmD, Tombleson, Rebecca, PharmD, Betcher, Jeffrey Alan, BS Pharm, Eddy, Beth, PharmD, Khan, Tippu, PharmD, Mayor, JoAl, PharmD, Bookout, Ryan, PharmD, Saunders, Ila Maewal, PharmD

Get full text

Evaluation of Melphalan 1-Day Versus 2-Day Dosing in Patients with Multiple Myeloma Undergoing Autologous Stem Cell Transplantation by Parmar, Sapna, Bookout, Ryan, Shapiro, Jamie, Tombleson, Rebecca, Perkins, Janelle, Kim, Jongphil, Alsina, Melissa, Nishihori, Taiga

Get full text